S A Stacker - JoVE Visualize

Showing results (21-30 of 55) with videos related to

Pageof 6

Sort By:

Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992

RYK, a receptor tyrosine kinase-related molecule with unusual kinase domain motifsC M Hovens, S A Stacker, A C Andres, et al.

British Journal of Cancer|April 1, 1989

Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2S A Stacker, J J Tjandra, P X Xing, et al.

British Journal of Cancer|July 1, 1991

The prognostic value of immunoperoxidase staining with monoclonal antibodies NCRC-11 and 3E1.2 in breast cancerI M Muir, R G Reed, S A Stacker, et al.

Molecular Medicine (Cambridge, Mass.)|January 10, 2002

VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiformeW Debinski, B Slagle-Webb, M G Achen, et al.

Cancer Research|December 15, 1988

Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2S A Stacker, C H Thompson, N P Sacks, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 22, 1998

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)M G Achen, M Jeltsch, E Kukk, et al.

Developments in Biological Standardization|January 1, 1987

Mammary serum antigen (MSA) levels as a marker for breast cancer: a survey of blood donors and patients with cancerS A Stacker, C H Thompson, M G Lowe, et al.

Growth Factors (Chur, Switzerland)|May 4, 2001

The 3T3-L1 fibroblast to adipocyte conversion is accompanied by increased expression of angiopoietin-1, a ligand for tie2S A Stacker, A S Runting, C Caesar, et al.

British Journal of Cancer|March 1, 1988

Evaluation of MSA as a serum marker in breast cancer: a comparison with CEAS A Stacker, N P Sacks, J Golder, et al.

Lancet (London, England)|December 1, 1984

Immunoscintigraphy for detection of lymph node metastases from breast cancerC H Thompson, M Lichtenstein, S A Stacker, et al.

Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:

Pageof 6

Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992

RYK, a receptor tyrosine kinase-related molecule with unusual kinase domain motifsC M Hovens, S A Stacker, A C Andres, et al.

British Journal of Cancer|April 1, 1989

Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2S A Stacker, J J Tjandra, P X Xing, et al.

British Journal of Cancer|July 1, 1991

The prognostic value of immunoperoxidase staining with monoclonal antibodies NCRC-11 and 3E1.2 in breast cancerI M Muir, R G Reed, S A Stacker, et al.

Molecular Medicine (Cambridge, Mass.)|January 10, 2002

VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiformeW Debinski, B Slagle-Webb, M G Achen, et al.

Cancer Research|December 15, 1988

Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2S A Stacker, C H Thompson, N P Sacks, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 22, 1998

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)M G Achen, M Jeltsch, E Kukk, et al.

Developments in Biological Standardization|January 1, 1987

Mammary serum antigen (MSA) levels as a marker for breast cancer: a survey of blood donors and patients with cancerS A Stacker, C H Thompson, M G Lowe, et al.

Growth Factors (Chur, Switzerland)|May 4, 2001

The 3T3-L1 fibroblast to adipocyte conversion is accompanied by increased expression of angiopoietin-1, a ligand for tie2S A Stacker, A S Runting, C Caesar, et al.

British Journal of Cancer|March 1, 1988

Evaluation of MSA as a serum marker in breast cancer: a comparison with CEAS A Stacker, N P Sacks, J Golder, et al.

Lancet (London, England)|December 1, 1984

Immunoscintigraphy for detection of lymph node metastases from breast cancerC H Thompson, M Lichtenstein, S A Stacker, et al.

Pageof 6